Genflow Biosciences PLC

GENF

Company Profile

  • Business description

    Genflow Biosciences PLC is a preclinical biotechnology company focused on developing biological interventions aimed at tackling the effects of aging, potentially slowing or halting the aging process, and reducing the incidence of age-related diseases and thereby increasing life span. The company is also focused on longevity and the development of therapies to counteract the effects of aging and diseases associated with age.

  • Contact

    6 Heddon Street
    LondonW1B 4BT
    GBR

    T: +44 2081425409

    E: [email protected]

    https://www.genflowbio.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2026

    Employees

    5

Stocks News & Analysis

stocks

Procter & Gamble earnings: Frigid sales and margins don’t suggest cracks in its standing

North America was a notable blemish, down 2% on an organic basis.
stocks

Our view on Santos after production is ramped up

Barossa at 75% capacity and Pikka undergoing commissioning.
stocks

GE Aerospace earnings: No good deed goes unpunished

We’ve raised our fair value estimate of GE Aerospace stock.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,189.9015.700.17%
CAC 408,143.055.84-0.07%
DAX 4024,900.7144.240.18%
Dow JONES (US)49,084.61299.40-0.61%
FTSE 10010,143.446.61-0.07%
HKSE26,749.51119.550.45%
NASDAQ23,539.62103.600.44%
Nikkei 22553,846.87157.980.29%
NZX 50 Index13,448.24108.63-0.80%
S&P 5006,919.926.570.10%
S&P/ASX 2008,860.1015.000.17%
SSE Composite Index4,136.1613.590.33%

Market Movers